Search by Drug Name or NDC
NDC 00299-5962-30 Dysport 300 U/1 Details
Dysport 300 U/1
Dysport is a INTRAMUSCULAR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Galderma Laboratories, L.P.. The primary component is BOTULINUM TOXIN TYPE A.
Product Information
| NDC | 00299-5962 |
|---|---|
| Product ID | 0299-5962_11af31e7-1043-454a-9570-4b2e9cb79a23 |
| Associated GPIs | 74400020032115 |
| GCN Sequence Number | 066833 |
| GCN Sequence Number Description | abobotulinumtoxinA VIAL 300 UNIT INTRAMUSC |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 29243 |
| HICL Sequence Number | 036477 |
| HICL Sequence Number Description | ABOBOTULINUMTOXINA |
| Brand/Generic | Brand |
| Proprietary Name | Dysport |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Botulinum Toxin Type A |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 300 |
| Active Ingredient Units | U/1 |
| Substance Name | BOTULINUM TOXIN TYPE A |
| Labeler Name | Galderma Laboratories, L.P. |
| Pharmaceutical Class | Acetylcholine Release Inhibitor [EPC], Acetylcholine Release Inhibitors [MoA], Neuromuscular Blockade [PE], Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125274 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00299-5962-30 (00299596230)
| NDC Package Code | 0299-5962-30 |
|---|---|
| Billing NDC | 00299596230 |
| Package | 1 VIAL in 1 CARTON (0299-5962-30) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
| Marketing Start Date | 2009-11-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |